GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
164.98
-5.12 (-3.01%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close170.10
Open170.01
Bid163.00 x 800
Ask164.98 x 900
Day's Range163.00 - 172.50
52 Week Range96.42 - 174.50
Volume930,993
Avg. Volume426,703
Market Cap4.653B
Beta3.03
PE Ratio (TTM)N/A
EPS (TTM)-8.74
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est172.11
Trade prices are not sourced from all markets
  • Is Pot Stock GW Pharmaceuticals Undervalued?
    Motley Fool2 days ago

    Is Pot Stock GW Pharmaceuticals Undervalued?

    The upcoming launch of its marijuana medicine for epilepsy could send sales surging.

  • Why GW Pharmaceuticals Stock Is Jumping Again Today
    Motley Fool3 days ago

    Why GW Pharmaceuticals Stock Is Jumping Again Today

    Momentum for the cannabis-focused biotech continues after Wednesday's report of a positive move by the DEA.

  • Why GW Pharmaceuticals, Baidu, and W&T Offshore Jumped Today
    Motley Fool3 days ago

    Why GW Pharmaceuticals, Baidu, and W&T Offshore Jumped Today

    Get the latest on these big winners.

  • InvestorPlace4 days ago

    GWPH Stock Surges on Reclassification of Epidiolex

    GW Pharmaceuticals (NASDAQ:GWPH) shares were surging on Wednesday as the U.S. Drug and Enforcement Administration (DEA) has plans to reclassify one of its medications. The company’s shares were on the rise, while trading volume was also soaring by more than four times the company’s daily average following a report from Morgan Stanley’s David Lebowitz. The report claimed that the agency has plans to reclassify the company’s Epidiolex (cannabidiol), which will now be allowed for medicinal use.

  • Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports
    Zacks4 days ago

    Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports

    Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.

  • ACCESSWIRE4 days ago

    CBD Stocks Set to Explode

    HENDERSON, NV / ACCESSWIRE / September 19, 2018 / It's just a matter of time before medical marijuana will become legal in all 50 states. It's not surprising when you consider a recent poll shows 93% of ...

  • Benzinga4 days ago

    Morgan Stanley: DEA Likely To Reclassify GW Pharma's Cannabinoid Therapy For US Launch

    Morgan Stanley expects the DEA to drop Epidiolex from Schedule I — the same level as cocaine, heroin and other illegal substances — to Schedule IV, where Xanax, Ambien and Tramadol rank. At worst, it would fall to Schedule III alongside moderately to lowly addictive drugs like codeine and anabolic steroids, Lebowitz said.

  • GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%
    Zacks4 days ago

    GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%

    GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

  • ACCESSWIRE4 days ago

    Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Pfizer

    NEW YORK, NY / ACCESSWIRE / September 19, 2018 / U.S. markets closed up Tuesday on the strength of upbeat corporate earnings and strong economic data. On Tuesday, China announced tariffs of between 5 to ...

  • Pot stocks are soaring again with Tilray surging 50% in single day
    CNBC4 days ago

    Pot stocks are soaring again with Tilray surging 50% in single day

    Tilray CEO Brendan Kennedy told CNBC that pharmaceutical companies must start thinking about partnering with cannabis producers as a "hedge" against the space.

  • Lacking quality weed extract, US researchers turn to Canada
    Associated Press5 days ago

    Lacking quality weed extract, US researchers turn to Canada

    SAN DIEGO (AP) — In a rare move, the U.S. government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for medical studies.

  • Motley Fool8 days ago

    Should You Invest in Marijuana Stocks?

    All you need to know to make an informed decision about investing in high-growth -- but high-risk -- marijuana stocks.

  • The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW
    Zacks9 days ago

    The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW

    The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW

  • ACCESSWIRE9 days ago

    Massively Undervalued CBD Companies

    HENDERSON, NV / ACCESSWIRE / September 13, 2018 / CBD stocks have been lining the pockets of their investors for years now. Unfortunately, many of them have been doing so well it can be argued that a majority ...

  • ETFs & Stocks to Tap Marijuana Boom
    Zacks10 days ago

    ETFs & Stocks to Tap Marijuana Boom

    Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.

  • Investors in This Top Marijuana Stock Can't Overlook These 2 Serious Challenges
    Motley Fool10 days ago

    Investors in This Top Marijuana Stock Can't Overlook These 2 Serious Challenges

    Though this pot stock has been unstoppable for years, things may not stay that way for much longer.

  • 9 Marijuana Stocks to Play the Pot Craze
    InvestorPlace12 days ago

    9 Marijuana Stocks to Play the Pot Craze

    Marijuana stocks, fueled by what may well be the biggest legal and medical revolution in years, have already proven they’re blazing their own trail. In all cases, though, there’s explosive potential on the table — the legal marijuana industry’s story has just gotten that compelling, as more states seek to legalize it while regulators finally start to see its legitimate medical benefits. Of all the marijuana stocks worth a look right now, Canopy Growth (NYSE:CGC) has garnered the most attention of late.

  • 4 Niche Marijuana Stocks With Massive Market Share
    Motley Fool12 days ago

    4 Niche Marijuana Stocks With Massive Market Share

    These pot stocks will likely play an important role for the weed industry.

  • Investopedia13 days ago

    A Marijuana ETF Just Crossed $1B in Assets

    Surging investor appetite for pot stocks has led one cannabis-focused exchange-traded fund (ETF) to break the billion-dollar mark for the first time. In a press release, The Horizons Marijuana Life Sciences Index ETF ( HMMJ), which offers direct exposure to North American-listed companies with business activities in the marijuana industry, said its total assets under management have grown to more than $1 billion Canadian dollars —  $760 million U.S. dollars at the current exchange rate. The ETF’s shares have surged 43% in the past month, according to CNBC, and 124% since it debuted on the Toronto Stock Exchange in April 2017 as investor enthusiasm for its top holdings continues to soar.

  • Motley Fool14 days ago

    The U.S. Has a Marijuana Legalization Catch-22 on Its Hands

    Hypothetically speaking, the federal government could be in a lose-lose situation if it legalizes recreational cannabis.

  • Midterm Elections Could Be a Turning Point for Marijuana
    Motley Fool15 days ago

    Midterm Elections Could Be a Turning Point for Marijuana

    There's a lot riding on the results of November's elections for the U.S. pot industry.

  • ACCESSWIRE19 days ago

    CBD Stocks Making Investors Big Profits

    HENDERSON, NV / ACCESSWIRE / September 4, 2018 / Very interesting Hemp, and CBD firm that we have discovered is CIIX. CIIX it appears is positioning itself to become China's GW Pharma (NASDAQ: GWPH). Just ...

  • 3 Industries Looking to Partner With Marijuana Stocks
    Motley Fool21 days ago

    3 Industries Looking to Partner With Marijuana Stocks

    The green rush is catching the eye of more than just investors.

  • Is GW Pharmaceuticals PLC a Buy?
    Motley Fool21 days ago

    Is GW Pharmaceuticals PLC a Buy?

    It's the biggest marijuana-focused biotech on the market. But will GW deliver for investors over the long run?

  • Nearly 37 Million Americans Used Marijuana in 2017
    Motley Fool22 days ago

    Nearly 37 Million Americans Used Marijuana in 2017

    The United States would likely be the world's most lucrative cannabis market... if not for the federal government.